Under the structure of the transaction, the aggregate investment amount will be up to $15 million invested in two tranches of $7.5 million each and divided among a group of institutional and accredited investors in varying percentages.
More Articles on Orthopedic Devices:
40 Orthopedic & Spine FDA 510(k) Device Clearances in July
Misonix Adds 6 Spine Sales Agencies
FDA Proposes New 510(k) Process to Ensure Application Completeness
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.